Germany's pharmaceutical manufacturing industry is pivotal to global healthcare, focused on producing essential medications and innovative therapies. This dynamic sector includes major players—from established corporations to niche enterprises—offering a wide range of products, including pharmaceuticals, biopharmaceuticals, and generics. As healthcare demands evolve, the industry is increasingly leaning into biotechnological advancements and personalized medicine. Germany stands out with its stringent regulatory frameworks and robust infrastructure, fostering innovation and high-quality manufacturing. It also benefits from strong investments in R&D, aiding both homegrown and international companies aiming to expand their footprints in the competitive pharmaceutical landscape.

The companies featured in this list are primarily based in various German regions, such as Bavaria and Lower Saxony. They vary in size from small firms employing near 50 people to significant organizations with over 5,000 employees. Founded between the early 20th century and the last decade, these companies specialize in an array of areas, from generic drugs to high-potency biopharmaceuticals. Noteworthy firms include MSD Sharp & Dohme GmbH and Aenova Group, demonstrating Germany's long-standing commitment to health innovation through a robust manufacturing infrastructure.

Continue reading to discover the top pharmaceutical manufacturing companies in Germany.

Top 19 Pharmaceutical Manufacturing Companies in Germany

1. MSD Sharp & Dohme GmbH

• Website: msd.de
• Ownership type: Private
• Headquarters: Amt Neuhaus, Lower Saxony, Germany
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: msd-sharp-%26-dohme-gmbh

MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of innovative medications and vaccines. MSD focuses on critical therapeutic areas, including oncology, infectious diseases, and vaccines, striving to enhance health outcomes for patients worldwide. The company serves healthcare providers, hospitals, and patients, emphasizing accessibility to healthcare solutions. With a workforce of approximately 2,438 employees, MSD is recognized as one of the prominent pharmaceutical manufacturers in Germany, contributing significantly to the industry through its commitment to clinical research and development. Their pipeline includes various promising therapies aimed at addressing pressing health challenges, showcasing their active role in advancing medical science.

2. Aenova Group

• Website: aenova-group.com
• Ownership type: Corporate
• Headquarters: Starnberg, Bavaria, Germany
• Employee distribution: Italy 46%, Germany 40%, Switzerland 7%, Other 7%
• Latest funding: April 2024
• Founded year: 2008
• Headcount: 1001-5000
• LinkedIn: aenova-group

Aenova Group, founded in 2008 and headquartered in Starnberg, Bavaria, Germany, is a pharmaceutical manufacturer and contract development organization. The company specializes in providing comprehensive services in pharmaceutical manufacturing, development, and packaging. Aenova serves a wide array of clients in the pharmaceutical and healthcare sectors, offering solutions for various dosage forms, including solids, semi-solids, liquids, and sterile products. With 14 production sites across Europe and the USA, Aenova is equipped with modern technologies and adheres to high-quality standards, ensuring reliable service delivery. The company also has a notable presence in the animal health sector, producing pharmaceuticals for both companion and farm animals. Aenova's commitment to innovation is reflected in its recent expansions and enhancements in manufacturing capabilities, particularly in high-potent medicines and specialized packaging solutions.

3. Tiefenbacher Group

• Website: tiefenbachergroup.com
• Ownership type: Family Owned
• Headquarters: Hamburg, Hamburg, Germany
• Employee distribution: India 56%, Germany 43%
• Founded year: 1963
• Headcount: 501-1000
• LinkedIn: alfred-e.-tiefenbacher-gmbh-%26-co.-kg-

Tiefenbacher Group, founded in 1963 and based in Hamburg, Germany, is a family-owned healthcare company dedicated to improving patient health through the development, manufacturing, and distribution of pharmaceuticals and medical devices. With a workforce of approximately 800 employees, the company operates globally, focusing on making high-quality healthcare products affordable and accessible. Their portfolio includes a wide range of finished dosage forms such as tablets, capsules, and patches, as well as raw materials and medical devices. The company prides itself on its patient-centric approach, emphasizing innovation and efficiency in its operations. They have successfully obtained over 15,000 marketing authorizations across more than 80 countries, showcasing their capability to navigate complex regulatory environments. Their commitment to quality is reflected in their adherence to Good Manufacturing Practices (GMP) and their state-of-the-art manufacturing facilities in India and Cyprus. Through a combination of in-house development and strategic partnerships, Tiefenbacher Group aims to deliver effective healthcare solutions that meet the needs of patients worldwide.

4. IDT Biologika

• Website: idt-biologika.com
• Ownership type: Corporate
• Headquarters: Dessau-Roßlau, Saxony-Anhalt, Germany
• Employee distribution: Germany 87%, United States (USA) 12%
• Latest funding: $243.8M, June 2024
• Founded year: 1921
• Headcount: 1001-5000
• LinkedIn: idt-biologika-gmbh

IDT Biologika, established in 1921 and headquartered in Dessau-Roßlau, Germany, operates as a contract development and manufacturing organization (CDMO) within the biopharmaceutical industry. The company specializes in the development and manufacturing of vaccines, cell and gene therapies, and other biologics. With a workforce of around 1,700 employees, IDT Biologika serves pharmaceutical and biotech companies, offering expertise in regulatory compliance and high-quality production processes. Their facilities are strategically located in Europe and North America, allowing them to provide end-to-end solutions for therapeutic product development. IDT Biologika has invested significantly in its operations, with over €600 million since 1993, including €400 million since 2011. The company has a strong track record in the industry, having completed more than 200 development, clinical, and commercial projects in recent years. Their commitment to quality is underscored by approvals from major regulatory bodies such as the EMA and FDA, and they have received multiple awards for their capabilities and service. Recently, they secured $243.75 million in funding, indicating ongoing growth and investment in their capabilities.

5. Dermapharm Holding SE

• Website: ir.dermapharm.de
• Ownership type: Corporate
• Headquarters: Flensburg, Schleswig-Holstein, Germany
• Employee distribution: Germany 88%, Spain 12%
• Latest funding: $495.0M, July 2022
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn: dermapharm-holding-se

Dermapharm Holding SE, based in Flensburg, Schleswig-Holstein, Germany, is a pharmaceutical manufacturer that specializes in branded medicines and health products. Established in 1991, the company has grown to employ between 1,001 and 5,000 people, with a significant portion of its workforce located in Germany and a smaller presence in Spain. Dermapharm focuses on in-house development and production, ensuring high-quality pharmaceutical solutions for healthcare professionals and organizations. The company boasts over 1,300 drug approvals and is actively engaged in more than 60 development projects, showcasing its commitment to innovation and market responsiveness. Dermapharm's recent funding of €495 million in July 2022 further underscores its growth potential and strategic positioning in the pharmaceutical industry.

6. Mundipharma Germany GmbH & Co. KG

• Website: mundipharma.de
• Ownership type: Private
• Headquarters: Frankfurt, Hesse, Germany
• Founded year: 1967
• Headcount: 51-200
• LinkedIn: mundipharma-vertriebsgesellschaft-mbh-%26-co--kg

Mundipharma Germany GmbH & Co. KG, founded in 1967 and based in Frankfurt, Hesse, is a private pharmaceutical company dedicated to research and development. The company specializes in creating innovative therapeutic solutions for serious health conditions, with a strong emphasis on oncology and pain management. Mundipharma's products are designed to meet the needs of healthcare professionals, hospitals, and patients, reflecting their commitment to patient-centered care. They actively collaborate with healthcare providers to enhance treatment outcomes, ensuring that their offerings are aligned with the latest medical practices. Mundipharma operates globally, with a presence in various regions including Europe, Asia, and Latin America, which allows them to address health challenges on an international scale. Their focus on specialty care and pain management, along with their recent strategic decisions to concentrate on prescription medications, underscores their commitment to advancing healthcare solutions.

7. TAD Pharma GmbH

• Website: tad.de
• Ownership type: Private
• Headquarters: Cuxhaven, Lower Saxony, Germany
• Employee distribution: Germany 87%, Iraq 13%
• Founded year: 1968
• Headcount: 201-500
• LinkedIn: tad-pharma

TAD Pharma GmbH, based in Cuxhaven, Lower Saxony, Germany, is a pharmaceutical company that specializes in the production and distribution of human and veterinary medicines, as well as medical products. Established in 1968, TAD Pharma initially focused on veterinary products but expanded into human medicine shortly thereafter. The company has a robust portfolio that includes over 120 active ingredients, with a strong emphasis on generics. TAD Pharma serves healthcare professionals, pharmacies, and veterinary clinics, providing essential medications for various health conditions. They maintain a commitment to quality, ensuring compliance with international Good Manufacturing Practice (GMP) standards. As part of the Krka Group, TAD Pharma benefits from enhanced resources and expertise, further solidifying its position in the pharmaceutical market. The company is recognized as one of the top ten generics manufacturers in Germany, particularly noted for its products in the cardiovascular and pain management categories.

8. HERMES ARZNEIMITTEL GmbH

• Website: hermes-arzneimittel.com
• Ownership type: Family Owned
• Headquarters: Pullach, Bavaria, Germany
• Employee distribution: Germany 94%, Austria 6%
• Founded year: 1907
• Headcount: 201-500
• LinkedIn: hermes-arzneimittel-gmbh

HERMES ARZNEIMITTEL GmbH, based in Pullach, Bavaria, Germany, is a family-owned pharmaceutical company founded in 1907. The company specializes in the development, manufacturing, and marketing of health products and over-the-counter (OTC) medications. With around 150 employees, HERMES ARZNEIMITTEL operates both domestically and internationally, serving pharmacies and consumers alike. The company boasts a portfolio of over 30 successful OTC brands, generating an annual revenue exceeding 100 million euros. HERMES ARZNEIMITTEL is committed to quality and customer satisfaction, ensuring that their products meet high standards of efficacy and safety. They have established partnerships in approximately 30 countries, showcasing their capability to navigate international markets. The company is focused on growth and aims to rank among the top 10 OTC manufacturers in Germany in the near future.

9. Nordmark Pharma GmbH

• Website: nordmark-pharma.de
• Ownership type: Private
• Headquarters: Uetersen, Schleswig-Holstein, Germany
• Employee distribution: Germany 99%, Other 1%
• Founded year: 2001
• Headcount: 501-1000
• LinkedIn: nordmark-pharma-gmbh

Nordmark Pharma GmbH, founded in 2001 and based in Uetersen, Schleswig-Holstein, Germany, is a private pharmaceutical manufacturer that specializes in biopharmaceutical active ingredients and medicines. The company offers a comprehensive range of drug development and manufacturing services tailored to the needs of pharmaceutical companies and healthcare organizations. With a workforce of around 215 employees, Nordmark emphasizes quality and compliance in its operations, ensuring that it meets the rigorous standards expected in the pharmaceutical industry. The company is particularly noted for its production of pancreatic enzymes, collagenase, and thyroid extract, which are critical in various therapeutic areas. Nordmark operates under stringent cGMP conditions, ensuring that its products are of high quality and safety. Their commitment to innovation is evident in their ongoing development of new technologies and their expansion into fields such as hormone replacement therapy and stem cell research. This focus on both established and emerging markets positions Nordmark as a significant player in the pharmaceutical manufacturing sector.

10. SERVIER Deutschland GmbH

• Website: servier.de
• Ownership type: Private
• Headquarters: Flensburg, Schleswig-Holstein, Germany
• Employee distribution: Germany 100%
• Founded year: 1996
• Headcount: 201-500
• LinkedIn: servier-deutschland

SERVIER Deutschland GmbH, founded in 1996 and based in Flensburg, Schleswig-Holstein, is a private pharmaceutical company dedicated to developing innovative therapies for a range of medical conditions. The company specializes in areas such as cardiovascular diseases, cancer, and depression, emphasizing the importance of patient needs in their operations. They collaborate closely with healthcare providers to ensure effective treatment options are available. With a workforce of approximately 103 employees, SERVIER Deutschland is part of a larger global organization that operates in 150 countries, providing medications to patients worldwide. The company is committed to research and development, investing over 20% of its pharmaceutical revenues into this area, and actively participates in clinical studies to advance medical science. Their production capabilities are robust, with a significant portion of their pharmaceutical raw materials produced in France. This focus on innovation and patient care positions SERVIER Deutschland as a relevant player in the pharmaceutical manufacturing industry.

11. Rottendorf Pharma

• Website: rottendorf.com
• Ownership type: Private
• Headquarters: Ennigerloh, North Rhine-Westphalia, Germany
• Employee distribution: Germany 96%, France 3%
• Founded year: 1928
• Headcount: 1001-5000
• LinkedIn: rottendorfpharma

Rottendorf Pharma GmbH, based in Ennigerloh, North Rhine-Westphalia, Germany, is a contract development and manufacturing organization (CDMO) that has been active since its founding in 1928. The company specializes in oral solid dosage forms, providing a range of services that include product development, manufacturing, packaging, and analytical testing. Rottendorf Pharma operates as an extension of its clients' operations, primarily serving pharmaceutical companies that require reliable partners to streamline their processes and enhance their product offerings. The company prides itself on its extensive experience and technical expertise, which are critical in navigating the complexities of pharmaceutical manufacturing. Rottendorf Pharma is also known for its commitment to quality, maintaining full compliance with Good Manufacturing Practices (GMP) and undergoing regular inspections by regulatory authorities such as the EMA and FDA. With a workforce of over 1,000 employees, the company has a strong presence in Germany and a growing footprint in international markets, including a sales subsidiary in the USA.

12. Excella GmbH & Co. KG

• Website: excella-pharma-source.de
• Ownership type: Corporate
• Headquarters: Feucht, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: December 2007
• Founded year: 1913
• Headcount: 501-1000
• LinkedIn: excella-pharma-source

Excella GmbH & Co. KG, based in Feucht, Bavaria, Germany, is a pharmaceutical manufacturer with a history dating back to 1913. The company specializes in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Excella operates under high international standards, ensuring quality and compliance in all its processes. They provide comprehensive services that span from drug development to quality control, catering to a wide range of clients, including major pharmaceutical firms and emerging startups. The company is particularly noted for its expertise in high-potency drugs, focusing on areas such as cancer therapy and immunosuppression. With a workforce of around 650 employees, Excella prides itself on its experienced team and state-of-the-art facilities, which allow for efficient production and rigorous quality assurance. Their commitment to safety, environmental protection, and regulatory compliance further solidifies their standing in the pharmaceutical sector.

13. Alfa Pharma GmbH

• Website: alfapharma.eu
• Ownership type: Family Owned
• Headquarters: Heppenheim, Hesse, Germany
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: mpsv-pharma

Alfa Pharma GmbH, founded in 2014 and based in Heppenheim, Hesse, Germany, is a family-owned pharmaceutical and nutraceutical company. The firm specializes in the development and sale of innovative and generic products, addressing various health needs through a range of pharmaceuticals, medical devices, and nutraceuticals. Alfa Pharma serves healthcare providers, pharmacies, and consumers, primarily operating in the EU and emerging markets. The company emphasizes responsible innovation and quality management, which are central to its operations. Alfa Pharma's product portfolio includes generic drugs, medical devices, and nutraceuticals, such as vitamins and herbal supplements. Additionally, the company offers contract development and manufacturing organization (CDMO) services, including formulation development and research facilities, further solidifying its role in the pharmaceutical manufacturing sector.

14. hexal.de

• Website: hexal.de
• Ownership type: Corporate
• Headquarters: Radebeul, Saxony, Germany
• Latest funding: $8.3B, February 2005
• Founded year: 1986
• Headcount: 5001-10000
• LinkedIn: hexal.de

Hexal AG, based in Radebeul, Saxony, Germany, is a prominent pharmaceutical manufacturer specializing in generic medications. Founded in 1986, the company has established a robust portfolio that includes over 5,900 medicines targeting various therapeutic areas. Hexal's commitment to providing affordable treatment options makes it a vital player in the healthcare industry. The company serves a wide range of customers, including healthcare professionals and patients, ensuring that essential medications are accessible. Operating as a part of the Sandoz brand, Hexal benefits from a strong reputation in the market, further solidifying its role in the pharmaceutical manufacturing sector.

15. Amgen Deutschland

• Website: amgen.de
• Ownership type: Private
• Headquarters: Munich, Bavaria, Germany
• Employee distribution: Germany 97%, Jordan 3%
• Founded year: 1989
• Headcount: 501-1000
• LinkedIn: amgengermany

Amgen Deutschland, based in Munich, Bavaria, is a biotechnology company founded in 1989. It specializes in developing innovative therapies for serious diseases, with a strong emphasis on oncology and chronic inflammatory conditions. The company offers a range of biopharmaceutical products and biosimilars, demonstrating a commitment to improving patient outcomes through advanced medical solutions. Amgen Deutschland is dedicated to research and development in the life sciences, actively exploring biological mechanisms of diseases and the biotechnological manufacturing of medicines. Their initiatives include educational programs like the Amgen Biotech Experience and partnerships with academic institutions, reflecting their engagement in the scientific community. The company serves healthcare providers and patients, ensuring that their therapies are accessible and effective. With a workforce of around 97 employees in Germany and a small presence in Jordan, Amgen Deutschland is a vital part of the Amgen global network, contributing to the advancement of biotechnology in the pharmaceutical industry.

16. betapharm Arzneimittel GmbH

• Website: betapharm.de
• Ownership type: Corporate
• Headquarters: Augsburg, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: $577.4M, March 2006
• Founded year: 1993
• Headcount: 10001+
• LinkedIn: betapharm-arzneimittel-gmbh

betapharm Arzneimittel GmbH, established in 1993 and located in Augsburg, Bavaria, Germany, specializes in the production and distribution of generic medications. The company serves pharmacies and healthcare professionals, providing a wide range of affordable pharmaceutical products. With a focus on enhancing patient care, betapharm is dedicated to making quality medications accessible to a broader audience. The company is part of the international Dr. Reddy’s Laboratories group, which allows it to leverage global resources and expertise. betapharm's product portfolio includes over 150 active ingredients in more than 900 dosage forms, covering various therapeutic areas, including cardiology, neurology, and pain management. This extensive range underscores its commitment to addressing the healthcare needs of the population.

17. MIP Pharma Group

• Website: mip-pharma.de
• Ownership type: Private
• Headquarters: Blieskastel, Saarland, Germany
• Employee distribution: Germany 86%, Serbia 9%, Poland 3%, Other 3%
• Founded year: 1955
• Headcount: 201-500
• LinkedIn: mip-pharma

MIP Pharma Group, based in Blieskastel, Saarland, Germany, is a pharmaceutical company that specializes in the manufacturing and distribution of a wide array of medicines. With a history dating back to 1955, MIP Pharma has developed a strong reputation for producing both generic and original pharmaceutical products. The company operates modern production facilities that adhere to stringent quality standards, ensuring compliance with Good Manufacturing Practices (GMP). MIP Pharma primarily serves hospitals and healthcare providers, emphasizing the reliable supply of essential medications. Their product portfolio includes around 400 drug approvals, focusing on prescription generics, particularly in the area of anti-infectives like antibiotics. The company has also expanded its reach internationally, with operations in several Eastern European markets. MIP Pharma's commitment to customer service and product availability has earned them recognition as a top supplier in the clinical sector in Germany.

18. AET Laboratories (Subsidary of Alfred.E.Tiefenbacher, Germany)

• Website: aet.eu
• Ownership type: Family Owned
• Headquarters: Hamburg, Hamburg, Germany
• Employee distribution: India 100%
• Founded year: 2003
• Headcount: 51-200
• LinkedIn: aet-laboratories-subsidary-of-alfred.e.tiefenbacher-germany-

AET Laboratories, a subsidiary of Alfred E. Tiefenbacher, is based in Hamburg, Germany, and was founded in 2003. The company specializes in the development, manufacturing, and commercialization of generic, value-added, and innovative medicines. With a workforce of approximately 224 employees, AET Laboratories serves B2B clients in the pharmaceutical industry, focusing on delivering high-quality healthcare solutions and e-health products aimed at enhancing patient outcomes globally. Their operations are primarily based in India, where they maintain manufacturing facilities that support their extensive product pipeline. AET Laboratories has successfully developed over 180 dossiers, including highly potent drug formulations, and has obtained more than 15,000 marketing authorizations across 80 countries. This extensive reach and commitment to quality and innovation position AET Laboratories as a significant contributor to the pharmaceutical manufacturing sector.

19. Aristo Pharma GmbH

• Website: aristo-pharma.de
• Ownership type: Corporate
• Headquarters: Berlin, Berlin, Germany
• Employee distribution: Germany 77%, Poland 9%, Russia 4%, Other 10%
• Latest funding: $4.1M, March 2024
• Founded year: 2008
• Headcount: 1001-5000
• LinkedIn: aristo-pharma

Aristo Pharma GmbH, based in Berlin, Germany, is a pharmaceutical company that specializes in the production and distribution of high-quality medicines, including generics and over-the-counter products. Founded in 2008 from the merger of several traditional German pharmaceutical firms, Aristo Pharma has roots that trace back to 1875. The company operates multiple production sites across Germany and Spain, emphasizing its commitment to quality and domestic manufacturing. With a workforce of over 1,600 employees, Aristo Pharma serves healthcare providers, pharmacies, and patients in 39 countries, focusing on affordability and reliability in healthcare solutions. Their product portfolio includes a wide range of prescription and OTC medicines, from herbal remedies to modern medical products. Aristo Pharma also produces medicines for third-party customers, showcasing their manufacturing capabilities. The company is dedicated to maintaining high quality through Good Manufacturing Practice (GMP) guidelines, ensuring that their products meet rigorous standards. In March 2024, Aristo Pharma secured funding of €4,070,000, indicating ongoing investment in their operations and growth.

Pharmaceutical Manufacturing Insights: Key Companies in Germany

Want to Find More Pharmaceutical Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!